The physicochemical properties of a biomaterial surface, together with the antifouling
property of the device, that is, its long-term antibacterial performance, are crucial for …

Hospital-acquired infections (HAIs) pose one of the major challenges to therapeutic
applications of biomedical devices under clinically relevant conditions. A paradigm shift in …

Infections arising from bacterial adhesion and colonization on medical device surfaces are a
significant healthcare problem. Silver based antibacterial coatings have attracted a great …

Bacterial infection from medical devices is a major problem and accounts for an increasing
number of deaths as well as high medical costs. Many different strategies have been …

The most common type of adverse events in healthcare in Canada reported by the
Canadian Institute for Health Information (CIHI) are nosocomial infections. Amongst …

Biofilm production is the crucial pathogenic mechanism of the implant-associated infection
and a primary target for new anti-infective strategies. Silver nanoparticles (AgNPs) are …

A novel biomass‐mediated method to synthesize cellulose‐stabilized silver nanoparticles
(SNPs) and incorporate them into biocompatible/bioabsorbable poly‐l‐lactic acid (PLLA) for …

Nanosilver is regarded as a new generation of antibacterial agents and has great potential
to be utilized in antibacterial surface coatings for medical devices, food package and …

Implant infections due to bacterial biofilms constitute a major healthcare challenge today.
One way to address this clinical need is to modify the implant surface with an antimicrobial …

The development of antimicrobial biomaterials based on silver nanoparticles (SNP) has
attracted significant interest during the past decade. SNP have demonstrated very beneficial …